Marpai, Inc. (MRAI) stock
MRAIOTCServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$3.18+0.05 (+1.60%)
Close on Oct 19, 2026Market cap $82.24MP/E –Yield –
Marpai r&d expenses
Research and development expenses are spending on new products and technology.
Marpai's R&D Expenses for the twelve months ending Dec 31, 2025 was $7.00K, down 75.9% year over year. For fiscal 2025 it was $7.00K, down 75.9% from the year before. The highest annual figure on record is $3.71M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.00K | -75.9% |
| FY2024 | Dec 31, 2024 | $29.00K | -97.8% |
| FY2023 | Dec 31, 2023 | $1.31M | -64.6% |
| FY2022 | Dec 31, 2022 | $3.71M | +113.8% |
| FY2021 | Dec 31, 2021 | $1.73M | -1.8% |
| FY2020 | Dec 31, 2020 | $1.77M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $7.00K | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $7.00K | -65.0% |
| Q3 FY2024 | Sep 30, 2024 | $7.00K | -97.4% |
| Q2 FY2024 | Jun 30, 2024 | $8.00K | -98.5% |
| Q1 FY2024 | Mar 31, 2024 | $7.00K | -98.6% |
| Q4 FY2023 | Dec 31, 2023 | $20.00K | -98.0% |
| Q3 FY2023 | Sep 30, 2023 | $267.00K | -65.8% |
| Q2 FY2023 | Jun 30, 2023 | $523.00K | -60.1% |
| Q1 FY2023 | Mar 31, 2023 | $500.00K | -15.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.02M | +66.3% |
| Q3 FY2022 | Sep 30, 2022 | $781.75K | +37.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.31M | +358.8% |
| Q1 FY2022 | Mar 31, 2022 | $593.11K | +124.7% |
| Q4 FY2021 | Dec 31, 2021 | $615.77K | +128.5% |
| Q3 FY2021 | Sep 30, 2021 | $568.82K | +20.8% |
| Q2 FY2021 | Jun 30, 2021 | $285.36K | – |
| Q1 FY2021 | Mar 31, 2021 | $264.01K | – |
| Q4 FY2020 | Dec 31, 2020 | $269.46K | – |
| Q3 FY2020 | Sep 30, 2020 | $470.94K | – |
See a number that looks wrong?